Motivational interviewing to enhance psychosocial treatment attendance in people with SMI.
Motivational interviewing to enhance psychosocial treatment attendance in people with SMI.
复制标题
动机访谈可提高 SMI 患者的心理社会治疗出勤率。
DOI：
10.1016/j.schres.2022.06.015
复制
发表时间：
2022
影响因子：
4.5
通讯作者：
Martino,Steve
中科院分区：
文献类型：
--
作者：
Fiszdon,JoannaM;Choi,Jimmy;Wang,Kaicheng;Parente,LoriT;Hallinan,Sean;Burton,Emma;Bell,MorrisD;Martino,Steve
BackgroundWhile there is increasing support for the efficacy of psychosocial interventions for people with SMI, the real-world effectiveness of such treatments is diminished by lack of motivation for treatment, leading to poor treatment engagement/dropout. We sought to evaluate the efficacy of motivational interviewing (MI) in improving attendance in a full course of cognitive training, examine motivation level as a potential mechanism of action, and examine variables associated with initial engagement in the training.MethodsOne hundred fourteen participants with SMI were randomized to MI or sham control interview (CI), both of which were followed by a 4-month active phase during which participants could attend up to 50 unpaid cognitive training sessions.ResultsFidelity to the MI intervention was high, and MI condition was associated with increases in perceived value of training tasks and, to a lesser extent, how enjoyable/interesting they were rated. Twenty-nine percent of the full sample did not attend any training sessions. In ITT analyses, there was no significant between-group impact of MI on treatment attendance, though one emerged when participants who did not attend any sessions were excluded. Treatment attendance was predicted by the level of motivation achieved after the MI/CI intervention. Those who attended at least one training session (regardless of randomization) were more likely to believe they had cognitive impairments, had higher IQ and had less severe general psychiatric symptoms.ConclusionsMI showed some promise and may be a worthwhile addition to more comprehensive, robust efforts to promote initial treatment engagement and subsequent adherence.
